TY - JOUR
T1 - Histiocytic sarcoma with secondary involvement of the skin and expression of CD1a
T2 - Evidence of indeterminate cell differentiation?
AU - Frater, John L.
AU - Kling, Christopher W.
AU - Obadiah, Joseph M.
AU - Gardner, Laura J.
AU - Grosso, Leonard E.
AU - Resh, Brooke
AU - Hurley, M. Yadira
PY - 2006/6
Y1 - 2006/6
N2 - Background: Histiocytic sarcoma is an exceedingly rare malignant neoplasm composed of cells with a monocyte/macrophage phenotype. In the current nosology of histiocytic neoplasms, histiocytic sarcoma is separate from indeterminate cell histiocytosis, a generally benign disorder characterized by proliferation of a CD1a+ and S-100+ population of cells lacking Birbeck granules usually limited to the skin. Methods: We present a case of histiocytic sarcoma in a 64-year-old man presenting as a peritonsillar mass and secondarily involving the skin. Results: The malignant cells in the extracutaneous foci of disease expressed macrophage-associated antigens including S-100 but were CD1a-. The malignant cells in the skin coexpressed CD1a and S-100 but lacked ultrastructural features of Langerhans cells, findings indicative of indeterminate cells. Conclusions: We discuss the clinical and histopathologic differential diagnosis in association with prior reported cases of histiocytic sarcoma, particularly in cases involving the skin and cases expressing the Langerhans cell-associated antigen CD1a.
AB - Background: Histiocytic sarcoma is an exceedingly rare malignant neoplasm composed of cells with a monocyte/macrophage phenotype. In the current nosology of histiocytic neoplasms, histiocytic sarcoma is separate from indeterminate cell histiocytosis, a generally benign disorder characterized by proliferation of a CD1a+ and S-100+ population of cells lacking Birbeck granules usually limited to the skin. Methods: We present a case of histiocytic sarcoma in a 64-year-old man presenting as a peritonsillar mass and secondarily involving the skin. Results: The malignant cells in the extracutaneous foci of disease expressed macrophage-associated antigens including S-100 but were CD1a-. The malignant cells in the skin coexpressed CD1a and S-100 but lacked ultrastructural features of Langerhans cells, findings indicative of indeterminate cells. Conclusions: We discuss the clinical and histopathologic differential diagnosis in association with prior reported cases of histiocytic sarcoma, particularly in cases involving the skin and cases expressing the Langerhans cell-associated antigen CD1a.
UR - http://www.scopus.com/inward/record.url?scp=33744980226&partnerID=8YFLogxK
U2 - 10.1111/j.0303-6987.2006.00453.x
DO - 10.1111/j.0303-6987.2006.00453.x
M3 - Article
C2 - 16776720
AN - SCOPUS:33744980226
SN - 0303-6987
VL - 33
SP - 437
EP - 442
JO - Journal of cutaneous pathology
JF - Journal of cutaneous pathology
IS - 6
ER -